✦ LIBER ✦

A phase II study of pirarubicin in malignant pleural mesothelioma

✍ Scribed by E. Kaukel; G. Koschel; U. Gatzemeyer; E. Salewski

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 396 KB
Volume: 66
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19900815)66:4<651::aid-cncr2820660408>3.0.co;2-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of gemcitabine in patie

A phase II study of gemcitabine in patients with malignant pleural mesothelioma

✍ Jan P. van Meerbeeck; Paul Baas; Channa Debruyne; Harry J. Groen; Chris Manegold 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## BACKGROUND. Gemcitabine has shown activity in patients with less chemosensitive solid tumors. Phase II screening of novel drugs is an accepted method with which to investigate new therapies in malignant mesothelioma. The European Organization for Research and Treatment of Cancer-Lung Cancer Coo

Intrapleural administration of interleuk

Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma : A Phase II study

✍ Philippe Astoul; Diane Picat-Joossen; Jean-Regis Viallat; Christian Boutin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 1 views

## Background: The prognosis associated with malignant pleural mesothelioma (mpm) is poor in spite of surgery, radiotherapy, photodynamic therapy, or chemotherapy. therefore, new therapeutic strategies, including intrapleural immunotherapy, are being investigated. several clinical studies have demo

Intrapleural administration of interleuk

Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma : A Phase II study

✍ Theodore G. Karrison; Nicholas J. Vogelzang 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 1 views

## Stage I Renal Cell Carcinoma I read the report by Kinouchi et al., 1 in which they concluded that the tumor grading of renal cell carcinoma was not predictive of the survival of Robson Stage I patients. This does not mean that the three-grading system is worthless; the authors simply showed tha

Occupation and risk of malignant pleural

Occupation and risk of malignant pleural mesothelioma: A case–control study in Spain

✍ Antonio Agudo; Carlos A. González; María J. Bleda; José Ramírez; Santos Hernánde 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 2 views

Background The association of mesothelioma and asbestos exposure is well known, but some data suggest that probably many people are still being exposed to asbestos without knowing it. Methods Between 1993 and 1996, 132 cases (77% males) of histologically con®rmed malignant pleural mesothelioma and 2

A prospective study of detorubicin in ma

A prospective study of detorubicin in malignant mesothelioma

✍ Nicolas Colbert; Jean-Michel Vannetzel; Victor Izrael; Michel Schlienger; Bernar 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB 👁 2 views

Cisplatin in combination with irinotecan

Cisplatin in combination with irinotecan in the treatment of patients with malignant pleural mesothelioma : A pilot phase II clinical trial and pharmacokinetic profile

✍ Takashi Nakano; A. Philippe Chahinian; Miho Shinjo; Naoki Togawa; Atsushi Tonomu 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 1 views

The purpose of this study was to assess the efficacy and toxicity of a combination of cisplatin and irinotecan (CPT-11) in the treatment of patients with malignant pleural mesothelioma and to characterize the pharmacokinetic profiles of CPT-11 and its active metabolite, 7-ethyl-10-hydroxycamptotheci